Randomised trials: substudies and extended follow-up - A quick update
Coronary Interventions
Left main disease
Multivessel disease
NSTEMI
Other coronary interventions
Stable CAD
Hotline / Late-Breaking Trials
Theatre Havane
Anchorperson: Pedro Lemos
Spokesperson: Valeria Paradies
Discussants: Samir Alam, Antoinette Neylon, Ashok Seth, Huay Cheem Tan
Keep bIfurcation Single stenting Simple
Bernard Chevalier
Discussion and audience interaction
ORBITA2-Symptoms: the symptom-stratified analysis of ORBITA-2
Florentina Simader
Discussion and audience interaction
Does completeness of revascularisation affect clinical outcomes? Insights from REVIVED-BCIS2
Margaret Mcentegart
Discussion and audience interaction
Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis
Frederik Zimmermann
Discussion and audience interaction
Hybrid coronary revascularisation–10-year clinical outcomes of the prospective randomised study.
Mateusz Tajstra
Discussion and audience interaction
Long-term outcomes after immediate versus staged complete revascularisation in STEMI or NSTE-ACS
Roberto Diletti
Discussion and audience interaction
Improved DES for left main PCI in an all-comers population: 5-year results of the IDEAL-LM Trial
Robert Van Geuns
Discussion and audience interaction
